meglumine antimoniate has been researched along with Liver Cirrhosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azevedo, EG; Caliari, MMV; Castro, RS; de Amorim, IFG; Demicheli, C; Frezard, FJG; Michalick, MSM; Mosser, DM; Pereira, RA; Pinheiro, LJ; Pinto, AJW; Silva, SM; Tafuri, WL | 1 |
Bustamante, SE; Corbett, CE; Duarte, MI | 1 |
2 other study(ies) available for meglumine antimoniate and Liver Cirrhosis
Article | Year |
---|---|
Hepatic fibropoiesis in dogs naturally infected with Leishmania (Leishmania) infantum treated with liposome-encapsulated meglumine antimoniate and allopurinol.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Gene Expression Regulation; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Liver; Liver Cirrhosis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Random Allocation; Transforming Growth Factor beta; Vimentin | 2018 |
Regression of diffuse intralobular liver fibrosis associated with visceral leishmaniasis.
Topics: Adolescent; Animals; Antigens, Protozoan; Brazil; Hepatomegaly; Humans; Immunohistochemistry; Kupffer Cells; Leishmania infantum; Leishmaniasis, Visceral; Liver; Liver Cirrhosis; Male; Meglumine; Meglumine Antimoniate; Microscopy, Electron; Organometallic Compounds; Splenomegaly | 1993 |